Entries by

SenzaGen utökar marknadsnärvaron i USA genom licensavtal med MB Research Labs

SenzaGen har tecknat licensavtal med kontraktslaboratoriet (CRO) MB Research Labs, som är ledande inom GLP-toxikologiska in vitro-tester i USA. Avtalet är globalt och ger MB Research Labs rätt att marknadsföra och sälja SenzaGens djurfria testplattform GARD®. För SenzaGen innebär avtalet att man ytterligare stärker sin närvaro på den amerikanska marknaden.

SenzaGen increases its presence in the US via a license agreement with MB Research Labs

SenzaGen has signed a license agreement with the contract research organization (CRO), MB Research Labs, which is a leader in GLP in vitro toxicological testing in the United States. The agreement gives MB Research Labs the right to market and sell SenzaGen’s animal-free GARD™ test platform worldwide and also further strengthening SenzaGen’s presence in the US market.

SenzaGen tar ett första steg i Kina – samarbetar med ledande expert

SenzaGen (Nasdaq First North: SENZA) har inlett ett samarbete med Guangzhou Chn-Alternative Biotechnology Co., Ltd (CHNALT), en ledande aktör inom alternativa, djurfria testmetoder i Kina. Det nya samarbetet syftar till att etablera lokala nätverk och ge SenzaGens cellbaserade testmetod GARD® ett försprång in på den kinesiska marknaden den dag marknaden är fullt redo för djurfria testmetoder av kemikalier. Kina är en av världens största marknader med på sikt ett förväntat förbud mot djurförsök inom exempelvis kosmetika.

SenzaGen takes a first step into China – cooperates with leading expert

SenzaGen (Nasdaq First North: SENZA) has initiated a partnership with Guangzhou Chn-Alternative Biotechnology Co., Ltd (CHNALT), a leading provider of alternative, animal-free testing methods in China. The new collaboration aims to establish local networks and ensure SenzaGen with its GARD™ genome-based testing method has a strong position as China moves towards introduction of animal-free chemical testing methods. China is one of the world’s largest markets, with an expected ban on animal experiments in the cosmetics industry, for example.

Skin Sensitization Testing—What’s Next?

Int. J. Mol. Sci. 2019, 20(3), 666; https://doi.org/10.3390/ijms20030666   Gunilla Grundström and Carl A.K. Borrebaeck Abstract There is an increasing demand for alternative in vitro methods to replace animal testing, and, to succeed, new methods are required to be at least as accurate as existing in vivo tests. However, skin sensitization is a complex process […]

View Live: SenzaGen’s CEO at Financial Meetings Øresund

Live presentations at Financial Meetings Øresund’s event “Sverige fortsatt starkt för Life Science?” SenzaGen’s CEO Anki Malmborg Hager will share the inspiring story of SenzaGen and how SenzaGen’s platform GARD®, a group of tests for animal-free safety testing, can replace animal tests using genomics in test tubes to assess whether chemicals are allergenic or not. Watch live […]